Pharmacy

Bio-Rad Laboratories Inc recently declared the launch of new magnetic bead-based multiplex immunoassays for TGF-6, rat cytokines, rat diabetes and mouse TH17 cytokines. New assays are built on Luminex's MagPlex platform to take advantage of the magnetic beads workflow that simplifies assay preparation and reduces variability in results. Magnetic bead-based assays are compatible with both vaccuum and magnetic wash stations as well as  other Luminex xMAP platforms such as Bio Rad's Bio-Plex 200 and Bio-Plex 3D systems.

The Bio-Plex Pro rat cytokine assays and Bio-Plex Pro rat diabetes assays detect 25 rat cytokines and five rat diabetes biomarkers, respectively. Both pa to help researchers investigate mechanisms and   quantify biomarkers of diseases, such as   diabetes, rheumatoid arthritis, cardiovascular Alzheimer's and Parkinson's disease, and of those associated with neurological disorders and  inflammation. The Bio-Plex Pro TGF-6 assays detect the three is forms of the transforming growth factor beta: TGF- 61, TGF- 62 and TGF- B3. These assays are key to understanding the mechanism of TGF-6 signaling, which plays a major role in cancer, cardiovascular disease and fibrosis.The Bio-Plex Pro™ mouse Thl7 assays comprise 11 new targets and can be coupled with Bio-Rad's six existing Thl7 assays.